Yiqiu Yao
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Adalimumab Treatment Effects on Inflammation and Adipose Tissue Mitochondrial Respiration in Hidradenitis Suppurativa.
Journal: Endocrinology, diabetes & metabolism
Published: February 16, 2024
Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO).
Journal: The Lancet regional health. Europe
Published: January 26, 2023
Characteristics of patients with hidradenitis suppurativa and concomitant inflammatory bowel disease.
Journal: International journal of dermatology
Published: October 11, 2022
Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa.
Journal: Case reports in dermatology
Published: June 12, 2022
Biomarkers of Tissue Turnover and Systemic Inflammation Are Associated with Disease Severity and Activity in Patients with Hidradenitis Suppurativa.
Journal: The Journal of investigative dermatology
Published: April 21, 2022
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Journal: The British journal of dermatology
Published: January 10, 2022
Drug Survival of Biologics in Patients With Hidradenitis Suppurativa.
Journal: JAMA dermatology
Published: December 01, 2021
Decreased glomerular function is associated with disease severity in patients with hidradenitis suppurativa.
Journal: Health science reports
Published: October 07, 2021
Liver enzyme levels are associated with markers of systemic inflammation, disease severity, and metabolic syndrome in patients with hidradenitis suppurativa.
Journal: Health science reports
Published: January 17, 2021
Certolizumab pegol for hidradenitis suppurativa: Case report and literature review.
Journal: Dermatologic therapy
Published: September 04, 2020
Last Updated: 09/26/2026